ELITech is an in-vitro diagnostic company Hospitals and laboratories in more than 100 countries use ELITech’s products PAI invested in the business in 2017 UPDATED. PAI Partners will hit a 3.7x gross ...
TORINO, Italy--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR) announced today that it has entered into a definitive share purchase agreement with TecFin S.à r.l., a controlled affiliate of PAI ...
Bruker Corporation BRKR recently entered into a definitive share purchase agreement with TecFin S.à r.l., a controlled affiliate of the pre-eminent private equity firm PAI Partners, to acquire ...
Mirina, the new entity, gained Nanogen’s technology that aims to enhance miRNA drugs. Nanogen and The Elitech Group entered a definitive merger agreement. Separately, Nanogen also created a technology ...
SAN DIEGO (May 14, 2008) - Nanogen, Inc, developer of molecular and rapid diagnostic products, today announced that it has executed an asset purchase agreement with The Elitech Group ("Elitech"), a ...
Continuing its aggressive buying spree, Bruker Corp. entered into a definitive share purchase agreement with Tecfin S.à r.l. to acquire molecular diagnostics (MDx) company Elitechgroup SAS for €870 ...
Upon completion of the transaction, ELITech is expected to operate as a stand-alone entity within Bruker’s Microbiology and Infection Diagnostics division. Bruker plans to fund the acquisition with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results